The EndoBarrier is fundamentally a gastrointestinal impermeable barrier or a gastric sleeve that prevents food from coming in contact with the intestinal wall.

The EndoBarrier Gastric Sleeve is implanted endoscopically through the mouth and is placed in such a way that it lines the first two feet of the small intestine. This helps to prevent easy absorption of food as long as it remains in the sleeve and has huge impact on the person’s intake of nutrients and calories. The digestive enzymes are on the outside of the liner and the food and the digestive juices do not mix until 2 feet downstream in the small intestines.

The EndoBarrier received European CE mark approval for the treatment of type 2 diabetes and obesity in December 2009.

Currently the EndoBarrier is being considered as a prelude to gastric bypass surgery and hence is treated as a temporary fix. But, its future, as a non-surgical alternative to weight loss and diabetes type 2 treatment, is extremely promising.

Clinical trials to date demonstrated a significant weight loss and diabetes improvement achieved with the Endo-Barrier Gastrointestinal Liner.

Undoubtedly we will hear a lot more about this New Obesity Surgery/